|
Diabetes Care, Vol 22, Issue 7 1165-1170, Copyright © 1999 by American Diabetes Association
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes
SD Sibley, JE Hokanson, MW Steffes, JQ Purnell, SM Marcovina, PA Cleary and JD Brunzell
Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle 98195, USA. ssibley@u.washington.edu
OBJECTIVE: This population study examines the relationship between LDL
density and persistent albuminuria in subjects with type 1 diabetes at the
end of the Diabetes Control and Complications Trial (DCCT). RESEARCH DESIGN
AND METHODS: Subjects were classified as persistently normoalbuminuric
(albumin excretion rate [AER] < 30 mg/d, n = 1,056), microalbuminuric
(AER > or = 30-299 mg/day, n = 80), and macroalbuminuric (AER = 300
mg/day, n = 24) based on the last two AER measures. RESULTS: Triglyceride
(P < 0.01) and LDL cholesterol (P < 0.01) levels were higher in
macroalbuminuric subjects compared with normoalbuminuric subjects.
Cholesterol distribution by density-gradient ultracentrifugation showed an
increase in intermediate-density lipoprotein (IDL) and a shift in peak LDL
from buoyant toward more dense particles with progressive albuminuria. In
the entire group, there was a significant negative correlation between the
peak buoyancy of LDL particles and albuminuria (r = -0.238, P < 0.001, n
= 1,160). This correlation persisted in the normoalbuminuric DCCT group (r
= -0.138, P < 0.001, n = 1,056). CONCLUSIONS: As albuminuria increases
in subjects with type 1 diabetes, dyslipidemia occurs with an increase in
IDL and dense LDL that may lead to increased cardiovascular disease.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. H. de Boer, S. D. Sibley, B. Kestenbaum, J. N. Sampson, B. Young, P. A. Cleary, M. W. Steffes, N. S. Weiss, J. D. Brunzell, and for the Diabetes Control and Complications Trial/E
Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications Study
J. Am. Soc. Nephrol.,
January 1, 2007;
18(1):
235 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri, P. Beyer, R. W. Holl, and on behalf of the DPV Initiative of the German Work
Spectrum and Prevalence of Atherogenic Risk Factors in 27,358 Children, Adolescents, and Young Adults With Type 1 Diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)
Diabetes Care,
February 1, 2006;
29(2):
218 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Thomas, M. Rosengard-Barlund, V. Mills, M. Ronnback, S. Thomas, C. Forsblom, M. E. Cooper, M.-R. Taskinen, G. Viberti, and P.-H. Groop
Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes
Diabetes Care,
February 1, 2006;
29(2):
317 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Molitch, D. Rupp, and M. Carnethon
Higher Levels of HDL Cholesterol Are Associated With a Decreased Likelihood of Albuminuria in Patients With Long-Standing Type 1 Diabetes
Diabetes Care,
January 1, 2006;
29(1):
78 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Lyons, A. J. Jenkins, D. Zheng, D. T. Lackland, D. McGee, W. T. Garvey, and R. L. Klein
Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort
Invest. Ophthalmol. Vis. Sci.,
March 1, 2004;
45(3):
910 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Jenkins, T. J. Lyons, D. Zheng, J. D. Otvos, D. T. Lackland, D. McGee, W. T. Garvey, R. L. Klein, and The DCCT/EDIC Research Group
Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia
Diabetes Care,
March 1, 2003;
26(3):
810 - 818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P Garg and G. L Bakris
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Vascular Medicine,
February 1, 2002;
7(1):
35 - 43.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Chaturvedi, J. H. Fuller, and M.-R. Taskinen
Differing Associations of Lipid and Lipoprotein Disturbances With the Macrovascular and Microvascular Complications of Type 1 Diabetes
Diabetes Care,
December 1, 2001;
24(12):
2071 - 2077.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|